close

Enter

Log in using OpenID

Endometriosis Market 2018 – Assessment, Intelligence, Share Analysis and Industry Growth Report 2025

embed
AdroitMarketResearch.com include new Endometriosis Market research report market to its huge collection of research reports.
Adroit Market Research
Global Endometriosis Market
Size by Drug Type (NSAID’s, Gonadotropins Releasing
Hormone Agonists, Progestin, and Oral Contraceptive
Pills) by Region and Forecast 2018 to 2025
Single Use License: US$ 4150
+1 (214) 884-6068
[email protected]
www.adroitmarketresearch.com
Request Sample
Adroit Market Research
Global Endometriosis Market Size, Share , Price Analysis Report 2025
• Adroit Market Research launched a study titled, “Global Endometriosis Market Size by Drug Type (NSAID’s, Gonadotropins
Releasing Hormone Agonists, Progestin, and Oral Contraceptive Pills), by Region and Forecast 2018 to 2025”. The study
covers the global endometriosis drugs market value for a period ranging in between 2015 to 2025, where 2015 to 2017
imply the historical value with forecast between 2018 and 2025. The global endometriosis treatment market report also
includes qualitative insights of the market such as pipeline analysis, porters five forces analysis, drivers and restraints.
Trends for the global endometriosis diagnosis market have also been covered in this study.
• The global endometriosis market size is expected to reach USD 2.29 billion by 2025. The increasing female population
within the age group of 15-49 years across developed as well as developing economies is expected to fuel the
endometriosis drugs market growth over the forecast period. High prevalence of endometriosis among the female
population of reproductive age is expected to drive the endometriosis treatment market demand in the coming years.
• Symptoms such as pain instantly before and during a period, ovulation pain, and irregular or heavy bleeding during periods
have resulted in a significant decrease in working female population. Productivity loss of approximately 11 hours per week
has been observed in diagnosed patients. High prevalence, undefined etiology, and high productivity loss are major factors
resulting in a large number of research institutes and drug manufacturers engaging in research for optimum diagnosis and
treatment for the condition.
• Drug classes namely NSAID’s, gonadotropins releasing hormone agonists, oral contraceptives, and progestin therapy are
widely used for pain management post-diagnosis. Nonsteroidal anti-inflammatory drug segment dominated the global
endometriosis market by contributing major market share and is expected to maintain its dominance over the forecast
period contributing to40.6% of the revenues by 2025.
+1 (214) 884-6068
[email protected]
www.adroitmarketresearch.com
Adroit Market Research
Global Endometriosis Market Size, Share , Price Analysis Report 2025
• Presence of a large number of companies actively involved in clinical trials for disease management is expected to change
the current market dynamics in the coming years. In April 2018, Bayer in collaboration with Evotec announced phase I
trials of new small molecules for the treatment of endometriosis. Furthermore, as of January 2019, 24 studies are under
phase III and are expected to show positive results, which will provide opportunities for the further development of the
global endometriosis treatment market.
• North America dominated the global endometriosis market in 2017 and is expected to grow at a lucrative CAGR by 2025.
High prevalence within the U.S., coupled with the presence of a large number of working female population has created a
potential market for drug manufacturers. According to ENDOFOUND.ORG, 7 million women in the U.S. have
endometriosis. On the other hand, the financial burden of USD 87 billion has been estimated within the U.S. every year for
medical costs and reduced work productivity. Such factors are expected to support regional growth over the forecast
period.
• The global endometriosis market is marked by the presence of well-established drug manufacturers such as AstraZeneca,
Bayer AG, Neurocrine Biosciences, Inc., Meditrina Pharmaceuticals Inc. and many more. Major players within the market
are actively involved in clinical trials to develop novel treatment and diagnosis options to reduce the financial burden of
the medical condition.
• Browse the complete report on @ https://www.adroitmarketresearch.com/industryreports/endometriosis-market
+1 (214) 884-6068
[email protected]
www.adroitmarketresearch.com
Adroit Market Research
Key segments of the global endometriosis market
Drug Type Overview, 2015-2025 (USD million)
• NSAID’s
• Gonadotropins Releasing Hormone agonists
• Progestin
• Oral contraceptive pills
Regional Overview, 2015-2025 (USD million)
• North America
• Europe
• Asia Pacific
• Rest of the World
• Purchase a single user copy of the global endometriosis market [email protected]
https://www.adroitmarketresearch.com/researchreport/purchase/784
+1 (214) 884-6068
[email protected]
www.adroitmarketresearch.com
Adroit Market Research
About Us
Contact Us
Adroit Market Research is an India-based business analytics and consulting company. Our
target audience is a wide range of corporations, manufacturing companies, product/technology
development institutions and industry associations that require understanding of a market’s
size, key trends, participants and future outlook of an industry. We intend to become our
clients’ knowledge partner and provide them with valuable market insights to help create
opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At
our core, we are curious people who love to identify and understand industry patterns, create
an insightful study around our findings and churn out money-making roadmaps. Our analysts
have tracked high growth markets in chemicals & materials, healthcare & pharmaceuticals,
semiconductor & electronics, energy & power, food & retail, consumer goods, technology, and
machinery & equipment sectors across the world to identify new opportunities, potential
customers, prepare go-to-market (GTM) strategies, identify segments for revenue growth for
companies, and many more.
US Headquarters
3131 McKinney Ave Ste 600 Dallas,
TX 75204 ,U.S.A
+1 (214) 884-6068
[email protected]
Phone: +1 (214) 884-6068
Email: [email protected]
www.adroitmarketresearch.com
1/--pages
Report inappropriate content